CURE Innovation Commons announced today that it is welcoming 454 Life Sciences, a Roche Company, as a Founding Sponsor of The Commons, the exciting new office and laboratory space in Southeastern Connecticut.

454 Life Sciences has donated a state-of-the-art DNA sequencing system to The Commons.The GS Junior System can be used by life science researchers to perform a variety of sequencing applications and will be a valuable tool available to start-up and growing companies who locate there. The sequencer will also provide valuable hands-on biotech experience to students in the teaching laboratory at The Commons.

The Commons offers easy access to Boston, Providence, New Haven, and New York. To learn more, contact Kim Kelly, kkelly@cureconnect.org, or visit http://curecommons.org, for facility details, on-site services, sponsor opportunities, and application details.